Period | Baseline | Hypertonic saline infusion | Post hypertonic saline infusion | ||||
---|---|---|---|---|---|---|---|
0–90 min | 90–150 min | 150–180 min | 180–210 min | 210–240 min | 240–300 min | P (GLM within) | |
SBP (mmHg) | |||||||
Placebo | 118 ± 9 | 118 ± 10 | 117 ± 9 | 119 ± 10 | 117 ± 10 | 120 ± 9 | 0.001 |
Furosemide | 117 ± 7 | 120 ± 13 | 114 ± 6* | 111 ± 8* | 113 ± 8* | 116 ± 8 | |
P (GLM between) | 0.202 | ||||||
DBP (mmHg) | |||||||
Placebo | 68 ± 7 | 67 ± 7 | 64 ± 8* | 67 ± 7* | 66 ± 6* | 67 ± 8 | 0.003 |
Furosemide | 68 ± 6 | 69 ± 7 | 67 ± 8 | 66 ± 6* | 67 ± 7* | 66 ± 6* | |
P (GLM between) | 0.740 | ||||||
HR (beats/min) | |||||||
Placebo | 62 ± 10 | 66 ± 11* | 63 ± 11 | 64 ± 10* | 62 ± 10 | 64 ± 11* | 0.354 |
Furosemide | 61 ± 8 | 65 ± 10* | 63 ± 9* | 63 ± 8* | 64 ± 10* | 64 ± 10* | |
P (GLM between) | 0.875 |